UCSF AIDS Research Institute To Announce Major New Program In HIV Prevention On "World AIDS Day"

December 01, 1998

The UC San Francisco AIDS Research Institute (ARI) will launch three new programs in 1999 aimed at preventing HIV infection.

The new initiatives are being announced today, Tuesday, December 1, as part of "World AIDS Day" activities at UCSF.

"Despite all of our efforts, we can expect thousands of Americans and millions around the globe to become infected with HIV next year and each year thereafter. It is evident that existing strategies have only gone so far," said Thomas J. Coates, PhD, director of the UCSF ARI. "The goal of these new initiatives is to make sure prevention is working as well as it can while we are simultaneously working on an HIV vaccine and better therapies."

"We need to do all we can to prevent new HIV infections, and we feel these projects represent a new era in which prevention efforts bridge two worlds that have long been separated: the HIV-infected and the uninfected populations," he added.

The new program initiatives are: Later this year the UCSF ARI will announce major plans in the area of vaccine development, according to Coates. The research efforts will be focused on understanding the mechanisms underlying the body's ability to avoid HIV infection or to delay progression of infection.

"All in all, science is paying off. AIDS deaths have decreased by two-thirds, but new infections in the U.S. have not gone down in the U.S. and in the developing world have increased by 10 percent. We are continuing to do all that we can to prevent HIV through social, behavioral, and vaccine strategies, and our science will continue to pay off in the future," Coates said.

The UCSF ARI is an institute without walls that encompasses all UCSF AIDS programs under a single umbrella. It includes a dozen research institutes, a wide range of clinical, behavioral science, and policy programs, and nearly 1,000 investigators.
-end-


University of California - San Francisco

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.